nivolumab-daratumumab
Showing 1 - 1 of 1
Myeloma Trial in Netherlands (nivolumab-daratumumab, nivolumab-daratumumab with low-dose cyclophosphamide)
Active, not recruiting
- Myeloma
- nivolumab-daratumumab
- nivolumab-daratumumab with low-dose cyclophosphamide
-
Arnhem, Ge, Netherlands
- +8 more
Oct 5, 2021